← Eichor
Study identifier: NCT06030804 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

Condition: Elderly · Cancer Surgery · Dexmedetomidine  ·  Sponsor: Peking University First Hospital

PhaseNA
Planned participants4532
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersNo

About this study

Along with aging population, cancer incidence and mortality are increasing. However, despite advances in oncology and surgery, long-term survival of cancer patients is far from optimal. Dexmedetomidine is a highly selective alpha 2 adrenergic receptor agonist with sedative, analgesic, and anxiolytic effects. Studies showed that perioperative use of dexmedetomidine reduces delirium and some non-delirium complications after surgery. In long-term follow-up studies of older patients who, for other reasons, were randomized to receive either dexmedetomidine or placebo during intra- or postoperative period, dexmedetomidine use was associated with improved long-term survival. This multicenter randomized trial aims to investigate the effect of perioperative dexmedetomidine on long-term outcomes in older patients undergoing cancer surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Dong-Xin Wang, MD,PhD  ·  8610 83572784  ·  wangdongxin@hotmail.com

Jia-Hui Ma, PhD  ·  8610 83575138  ·  mjh@bjmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (39)

The First Affiliated Hospital of China University of Science and TechnologyHefei, Anhui, ChinaRecruiting
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)Hefei, Anhui, ChinaRecruiting
Peking University First HospitalBeijing, Beijing Municipality, ChinaRecruiting
Tsinghua University Yuquan HospitalBeijing, Beijing Municipality, ChinaRecruiting
Cancer Hospital Chinese Academy of Medical SciencesBeijing, Beijing Municipality, ChinaRecruiting
The First Affiliated Hospital of Army Medical University (Southwest Hospital)Chongqing, Chongqing Municipality, ChinaRecruiting
Fujian Provincial HospitalFuzhou, Fujian, ChinaRecruiting
The First Affiliated Hospital of Fujian Medical UniversityFuzhou, Fujian, ChinaRecruiting
Fujian Medical University Union HospitalFuzhou, Fujian, ChinaNot Yet Recruiting
Jinjiang City Hospital (Shanghai Sixth People's Hospital, Fujian Hospital)Jinjiang, Fujian, ChinaRecruiting
Guangdong General HospitalGuangzhou, Guangdong, ChinaRecruiting
Peking University Shenzhen HospitalShenzhen, Guangdong, ChinaRecruiting

+ 27 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06030804